Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Multicenter Pivotal Study to Evaluate the Treatment of Severe Aortic Valve Stenosis With Next-Generation Venus-Vitae Transcatheter Heart Valve (THV) System

NCT05991271 is registered in ClinicalTrials.gov with Venus MedTech (HangZhou) Inc. as lead sponsor.

NCT NCT05991271
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05991271 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Multicenter Pivotal Study to Evaluate the Treatment of Severe Aortic Valve Stenosis With Next-Generation Venus-Vitae Transcatheter Heart Valve (THV) System
Lead sponsor
Venus MedTech (HangZhou) Inc.
Phase
Not applicable
Overall status
Not yet recruiting
Start date
October 31, 2023
Completion date
June 30, 2029
Enrollment
150 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

aortic valve stenosis